|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP ISO
|
Aldicarb results in decreased activity of ACHE protein
|
CTD |
PMID:8134223 PMID:14644616 PMID:16256972 PMID:21251949 PMID:23962483 PMID:27132127 PMID:33844597 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of AGER mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
App
|
amyloid beta precursor protein
|
decreases response to substance
|
ISO
|
APP protein modified form results in decreased susceptibility to Aldicarb
|
CTD |
PMID:34902447 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of BAX protein robinin inhibits the reaction [Aldicarb results in increased expression of BAX protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
EXP
|
Aldicarb results in decreased expression of BCL2 protein robinin inhibits the reaction [Aldicarb results in decreased expression of BCL2 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CASP3 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CASP9 protein]
|
CTD |
PMID:39889879 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of CAT protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CCL2 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
Aldicarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
multiple interactions
|
EXP
|
Aldicarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Cst3
|
cystatin C
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of CST3 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of GSR protein]
|
CTD |
PMID:39889879 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of HAVCR1 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
| G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of HMGB1 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions decreases activity
|
EXP
|
robinin inhibits the reaction [Aldicarb results in decreased activity of HMOX1 protein]
|
CTD |
PMID:39889879 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Il1b
|
interleukin 1 beta
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of IL1B mRNA robinin inhibits the reaction [Aldicarb results in increased expression of IL1B mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
| G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Aldicarb results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Il6
|
interleukin 6
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of IL6 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of IL6 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
Aldicarb promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of MYD88 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of MYD88 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
increases phosphorylation
|
ISO
|
Aldicarb results in increased phosphorylation of NEFH protein
|
CTD |
PMID:16256972 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nrxn1
|
neurexin 1
|
multiple interactions
|
ISO
|
NRXN1 protein affects the reaction [NLG-1 results in increased susceptibility to Aldicarb]; NRXN1 protein affects the reaction [NRX-1 results in decreased susceptibility to Aldicarb]
|
CTD |
PMID:23638761 |
|
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
|
|
| G
|
Pax6
|
paired box 6
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of PAX6 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
Aldicarb inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions
|
ISO EXP
|
[Calcium results in increased activity of PON1 protein] which results in decreased susceptibility to Aldicarb; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to Aldicarb
|
CTD |
PMID:27132127 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of PTGS2 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of PTGS2 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of RELA mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Tlr4
|
toll-like receptor 4
|
increases expression multiple interactions
|
EXP
|
Aldicarb results in increased expression of TLR4 mRNA robinin inhibits the reaction [Aldicarb results in increased expression of TLR4 mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
| G
|
Tnf
|
tumor necrosis factor
|
multiple interactions increases expression
|
EXP
|
robinin inhibits the reaction [Aldicarb results in increased expression of TNF mRNA]
|
CTD |
PMID:39889879 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
| G
|
Vpreb1a
|
V-set pre-B cell surrogate light chain 1A
|
decreases expression
|
ISO
|
Aldicarb results in decreased expression of VPREB1 mRNA
|
CTD |
PMID:25424538 |
|
NCBI chr11:97,631,174...97,632,051
Ensembl chr11:97,629,102...97,632,051
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
aminocarb results in decreased activity of ACHE protein
|
CTD |
PMID:2086312 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO EXP
|
bendiocarb results in decreased activity of ACHE protein
|
CTD |
PMID:14644616 PMID:21251949 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
bendiocarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
multiple interactions
|
EXP
|
bendiocarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
bendiocarb inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases activity
|
ISO
|
bendiocarb results in increased activity of NFE2L2 protein
|
CTD |
PMID:20143881 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
bendiocarb inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
benfuracarb metabolite results in decreased activity of ACHE protein; benfuracarb results in decreased activity of ACHE protein
|
CTD |
PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases expression
|
ISO
|
benfuracarb results in increased activity of CYP2B6 protein benfuracarb results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
increases oxidation
|
ISO
|
CYP2C19 protein results in increased oxidation of benfuracarb
|
CTD |
PMID:24016712 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases activity increases expression multiple interactions increases metabolic processing
|
ISO
|
benfuracarb results in increased activity of CYP3A4 protein benfuracarb results in increased expression of CYP3A4 mRNA [CYP3A4 protein results in increased metabolism of benfuracarb] which results in increased chemical synthesis of Carbofuran
|
CTD |
PMID:22310298 PMID:24016712 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases expression increases activity
|
ISO
|
benfuracarb results in increased expression of NR1I3 mRNA benfuracarb results in increased activity of NR1I3 protein
|
CTD |
PMID:22310298 PMID:28927721 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions decreases activity
|
ISO EXP
|
[Carbaryl co-treated with Dichlorvos] results in decreased activity of ACHE protein; Obidoxime Chloride promotes the reaction [Carbaryl results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [Carbaryl results in decreased activity of ACHE protein] [Carbaryl co-treated with Chlorpyrifos] results in decreased activity of ACHE protein
|
CTD |
PMID:4859365 PMID:7713347 PMID:14644616 PMID:16256972 PMID:19934164 PMID:21251949 PMID:23418109 PMID:23962483 PMID:25707986 PMID:33844597 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Agxt
|
alanine--glyoxylate aminotransferase
|
decreases activity
|
EXP
|
Carbaryl results in decreased activity of AGXT protein
|
CTD |
PMID:2119399 |
|
NCBI chr 9:101,122,793...101,132,746
Ensembl chr 9:101,122,793...101,132,745
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
ISO EXP
|
AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Carbaryl binds to and results in increased activity of AHR protein; Carbaryl inhibits the reaction [beta-Naphthoflavone binds to and results in increased activity of AHR protein]
|
CTD |
PMID:9169082 PMID:9853009 PMID:17553063 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Alb
|
albumin
|
increases hydrolysis multiple interactions
|
EXP ISO
|
ALB protein results in increased hydrolysis of Carbaryl bis(4-nitrophenyl)phosphate inhibits the reaction [ALB protein results in increased hydrolysis of Carbaryl]
|
CTD |
PMID:27665777 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Ar
|
androgen receptor
|
affects binding
|
EXP
|
Carbaryl binds to AR protein
|
CTD |
PMID:14565775 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
| G
|
Bche
|
butyrylcholinesterase
|
decreases activity multiple interactions
|
EXP
|
Carbaryl results in decreased activity of BCHE protein [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:20708061 PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl2l11
|
Bcl2-like 11
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of BCL2L11 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
| G
|
Casp3
|
caspase 3
|
increases expression
|
EXP
|
Carbaryl results in increased expression of CASP3
|
CTD |
PMID:27296064 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cebpa
|
CCAAT/enhancer binding protein alpha
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of CEBPA mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
|
|
| G
|
Chrna3
|
cholinergic receptor nicotinic alpha 3 subunit
|
multiple interactions
|
EXP
|
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,297,755...64,311,251
Ensembl chr 8:64,297,755...64,311,412
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrnb2
|
cholinergic receptor nicotinic beta 2 subunit
|
multiple interactions
|
EXP
|
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 2:177,479,091...177,487,306
Ensembl chr 2:177,479,091...177,491,326
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
multiple interactions
|
EXP
|
Carbaryl results in decreased activity of [CHRNA3 protein binds to CHRNB4 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
increases activity increases expression multiple interactions
|
ISO EXP
|
Carbaryl results in increased activity of CYP1A1 protein Carbaryl results in increased expression of CYP1A1 mRNA; Carbaryl results in increased expression of CYP1A1 protein AHR protein affects the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; alpha-naphthoflavone inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]; Methoxsalen inhibits the reaction [Carbaryl results in increased expression of CYP1A1 mRNA]
|
CTD |
PMID:9169082 PMID:9858662 PMID:11226373 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions increases expression decreases activity
|
ISO EXP
|
Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol]; Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] Carbaryl results in increased expression of CYP1A2 protein Carbaryl results in decreased activity of CYP1A2 protein
|
CTD |
PMID:9858662 PMID:16790556 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases expression
|
ISO
|
Carbaryl results in increased activity of CYP2B6 protein Carbaryl results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions decreases activity
|
ISO
|
Carbaryl inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] Carbaryl results in decreased activity of CYP2E1 protein
|
CTD |
PMID:22634058 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases expression
|
ISO
|
Carbaryl results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
Carbaryl results in increased expression of DDIT3 mRNA
|
CTD |
PMID:11226373 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
| G
|
Dnajb4
|
DnaJ heat shock protein family (Hsp40) member B4
|
increases expression
|
ISO
|
Carbaryl results in increased expression of DNAJB4 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
|
|
| G
|
Dnajb9
|
DnaJ heat shock protein family (Hsp40) member B9
|
increases expression
|
ISO
|
Carbaryl results in increased expression of DNAJB9 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344
|
|
| G
|
Dnajc3
|
DnaJ heat shock protein family (Hsp40) member C3
|
increases expression
|
ISO
|
Carbaryl results in increased expression of DNAJC3 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:102,432,663...102,475,643
|
|
| G
|
E2f5
|
E2F transcription factor 5
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of E2F5 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 2:88,718,567...88,734,143
Ensembl chr 2:88,718,567...88,734,143
|
|
| G
|
Enc1
|
ectodermal-neural cortex 1
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of ENC1 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Carbaryl binds to and results in decreased activity of ESR1 protein; Carbaryl inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 PMID:16626760 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Esr2
|
estrogen receptor 2
|
multiple interactions decreases expression
|
ISO
|
Carbaryl binds to and results in decreased activity of ESR2 protein Carbaryl results in decreased expression of ESR2 mRNA
|
CTD |
PMID:16626760 PMID:27829164 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression decreases expression
|
ISO
|
Carbaryl results in increased expression of FOS mRNA Carbaryl results in decreased expression of FOS mRNA
|
CTD |
PMID:11226373 PMID:27829164 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Foxo1
|
forkhead box O1
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of FOXO1 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419
|
|
| G
|
Fshb
|
follicle stimulating hormone subunit beta
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA]; Carbaryl inhibits the reaction [FSHB protein results in increased secretion of Progesterone]
|
CTD |
PMID:16413094 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:114,003,262...114,007,072
|
|
| G
|
G6pd
|
glucose-6-phosphate dehydrogenase
|
increases activity multiple interactions
|
EXP
|
Carbaryl results in increased activity of G6PD protein [Malathion co-treated with Carbaryl] results in increased activity of G6PD protein; Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein]
|
CTD |
PMID:27214522 |
|
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:157,352,373...157,372,144
|
|
| G
|
Gadd45b
|
growth arrest and DNA-damage-inducible, beta
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of GADD45B mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718
|
|
| G
|
Gclm
|
glutamate cysteine ligase, modifier subunit
|
increases expression
|
ISO
|
Carbaryl results in increased expression of GCLM mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
|
|
| G
|
Gpx5
|
glutathione peroxidase 5
|
increases expression
|
ISO
|
Carbaryl results in increased expression of GPX5 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr17:48,131,853...48,138,801
Ensembl chr17:48,093,895...48,138,801
|
|
| G
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B
|
increases expression
|
EXP
|
Carbaryl results in increased expression of GRIN2B protein
|
CTD |
PMID:28975519 |
|
NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570
|
|
| G
|
Herpud1
|
homocysteine inducible ER protein with ubiquitin like domain 1
|
increases expression
|
ISO
|
Carbaryl results in increased expression of HERPUD1 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr19:10,604,360...10,624,168
Ensembl chr19:10,604,362...10,624,081
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
increases expression
|
ISO
|
Carbaryl results in increased expression of HMOX1 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
Carbaryl results in increased expression of HSPA5 mRNA
|
CTD |
PMID:11226373 PMID:27829164 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa6l-ps1
|
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of HSPA6 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr13:85,805,911...85,807,052
|
|
| G
|
Ifnb1
|
interferon beta 1
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]
|
CTD |
PMID:15907790 PMID:18177342 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
| G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Carbaryl analog results in decreased susceptibility to IL2 protein; Carbaryl results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Kyat1
|
kynurenine aminotransferase 1
|
decreases activity
|
EXP
|
Carbaryl results in decreased activity of KYAT1 protein
|
CTD |
PMID:2119399 |
|
NCBI chr 3:33,857,407...33,891,153
Ensembl chr 3:33,857,743...33,890,642
|
|
| G
|
Map2
|
microtubule-associated protein 2
|
multiple interactions
|
ISO
|
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of MAP2 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459
|
|
| G
|
Mitf
|
melanocyte inducing transcription factor
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of MITF mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:131,965,714...132,177,790
|
|
| G
|
Mtnr1a
|
melatonin receptor 1A
|
affects binding multiple interactions
|
ISO
|
Carbaryl binds to MTNR1A protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1A protein]
|
CTD |
PMID:28027439 |
|
NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421
|
|
| G
|
Mtnr1b
|
melatonin receptor 1B
|
affects binding multiple interactions
|
ISO
|
Carbaryl binds to MTNR1B protein Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]; Guanosine Triphosphate inhibits the reaction [Carbaryl inhibits the reaction [Melatonin binds to MTNR1B protein]]
|
CTD |
PMID:28027439 |
|
NCBI chr 8:20,919,593...20,934,109
Ensembl chr 8:20,919,593...20,934,109
|
|
| G
|
Nefh
|
neurofilament heavy chain
|
increases phosphorylation
|
ISO
|
Carbaryl results in increased phosphorylation of NEFH protein
|
CTD |
PMID:16256972 |
|
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:84,044,023...84,054,417
|
|
| G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein]
|
CTD |
PMID:15907790 PMID:17015962 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
| G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; Mercaptoethanol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]
|
CTD |
PMID:15907790 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
| G
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2
|
increases expression increases activity
|
ISO EXP
|
Carbaryl results in increased expression of NR1I2 mRNA Carbaryl results in increased activity of NR1I2 protein
|
CTD |
PMID:22310298 PMID:27665777 |
|
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:75,965,632...76,002,380
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases activity
|
EXP
|
Carbaryl results in increased activity of NR1I3 protein
|
CTD |
PMID:27665777 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
| G
|
Otx2
|
orthodenticle homeobox 2
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr15:24,422,876...24,432,709
Ensembl chr15:24,422,876...24,432,472
|
|
| G
|
Pax6
|
paired box 6
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of PAX6 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pdxk
|
pyridoxal kinase
|
decreases activity
|
ISO
|
Carbaryl results in decreased activity of PDXK protein
|
CTD |
PMID:2547861 |
|
NCBI chr20:10,209,975...10,232,012
Ensembl chr20:10,209,832...10,233,780
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pnpla6
|
patatin-like phospholipase domain containing 6
|
decreases activity
|
EXP
|
Carbaryl results in decreased activity of PNPLA6 protein
|
CTD |
PMID:7713347 |
|
NCBI chr12:6,372,284...6,401,632
Ensembl chr12:6,372,293...6,401,631
|
|
| G
|
Pou5f1
|
POU class 5 homeobox 1
|
multiple interactions
|
ISO
|
Carbaryl promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in decreased expression of POU5F1 mRNA]
|
CTD |
PMID:32949729 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598
|
|
| G
|
Ppara
|
peroxisome proliferator activated receptor alpha
|
increases activity
|
EXP
|
Carbaryl results in increased activity of PPARA protein
|
CTD |
PMID:27665777 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
|
|
| G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
Carbaryl inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
|
CTD |
PMID:15907790 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
| G
|
Star
|
steroidogenic acute regulatory protein
|
multiple interactions decreases expression
|
ISO
|
Carbaryl inhibits the reaction [FSHB protein results in increased expression of STAR mRNA] Carbaryl results in decreased expression of STAR mRNA
|
CTD |
PMID:16413094 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
|
|
| G
|
Tdo2
|
tryptophan 2,3-dioxygenase
|
decreases activity
|
ISO EXP
|
Carbaryl results in decreased activity of TDO2 protein
|
CTD |
PMID:2119399 PMID:2547861 |
|
NCBI chr 2:169,567,656...169,585,586
Ensembl chr 2:169,567,654...169,585,586
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression
|
ISO
|
Carbaryl results in increased expression of TGFB2 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions affects binding
|
ISO
|
Carbaryl binds to and results in decreased activity of THRB protein Carbaryl binds to THRB protein
|
CTD |
PMID:18584933 PMID:28973306 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
| G
|
Tpo
|
thyroid peroxidase
|
increases activity
|
ISO
|
Carbaryl results in increased activity of TPO protein
|
CTD |
PMID:21809831 |
|
NCBI chr 6:52,425,998...52,495,793
Ensembl chr 6:52,426,010...52,495,793
|
|
| G
|
Wnt6
|
Wnt family member 6
|
decreases expression
|
ISO
|
Carbaryl results in decreased expression of WNT6 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr 9:83,778,552...83,792,186
Ensembl chr 9:83,778,552...83,792,186
|
|
| G
|
Xbp1
|
X-box binding protein 1
|
increases expression
|
ISO
|
Carbaryl results in increased expression of XBP1 mRNA
|
CTD |
PMID:27829164 |
|
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:84,604,107...84,609,706
|
|
|
|
| G
|
A4galt
|
alpha 1,4-galactosyltransferase
|
affects response to substance
|
ISO
|
A4GALT gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22919386 |
|
NCBI chr 7:116,248,571...116,272,917
Ensembl chr 7:116,247,880...116,273,171
|
|
| G
|
Abhd2
|
abhydrolase domain containing 2, acylglycerol lipase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of ABHD2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:142,626,732...142,712,674
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO EXP
|
Carbofuran results in decreased activity of ACHE protein
|
CTD |
PMID:7966439 PMID:10918524 PMID:19934164 PMID:22209767 PMID:22807346 PMID:23611293 PMID:23962483 PMID:28725974 More...
|
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Adam8
|
ADAM metallopeptidase domain 8
|
increases expression
|
EXP
|
Carbofuran results in increased expression of ADAM8 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485
|
|
| G
|
Alb
|
albumin
|
affects binding multiple interactions increases secretion
|
ISO EXP
|
Carbofuran binds to ALB protein Plant Extracts inhibits the reaction [Carbofuran results in increased secretion of ALB protein]; Silymarin inhibits the reaction [Carbofuran results in increased secretion of ALB protein]
|
CTD |
PMID:27657490 PMID:34264070 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
| G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
increases expression multiple interactions
|
EXP
|
Carbofuran results in increased expression of BAX protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of BAX protein]
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
| G
|
Bcat1
|
branched chain amino acid transaminase 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of BCAT1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:179,695,662...179,777,973
Ensembl chr 4:179,695,662...179,777,288
|
|
| G
|
Bche
|
butyrylcholinesterase
|
decreases activity multiple interactions
|
ISO EXP
|
Carbofuran results in decreased activity of BCHE protein [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:17364237 PMID:22209767 PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of BCL2 protein
|
CTD |
PMID:30471306 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
| G
|
Casp3
|
caspase 3
|
decreases expression multiple interactions increases expression
|
EXP ISO
|
Carbofuran results in decreased expression of CASP3 protein modified form Carbofuran results in increased cleavage of and results in increased activity of CASP3 protein Carbofuran results in increased expression of CASP3 protein modified form 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of CASP3 protein modified form]
|
CTD |
PMID:22240977 PMID:25564422 PMID:28982980 PMID:30471306 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
Plant Extracts inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Silymarin inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]
|
CTD |
PMID:22807346 PMID:24865641 PMID:31334637 PMID:31696704 PMID:34264070 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Ccl7
|
C-C motif chemokine ligand 7
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CCL7 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947
|
|
| G
|
Ccnd1
|
cyclin D1
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of CCND1 mRNA; Carbofuran results in decreased expression of CCND1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of CCND1 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
| G
|
Ccr1
|
C-C motif chemokine receptor 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CCR1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374
|
|
| G
|
Cd14
|
CD14 molecule
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CD14 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292
|
|
| G
|
Cdk7
|
cyclin-dependent kinase 7
|
affects response to substance
|
ISO
|
CDK7 gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22102698 |
|
NCBI chr 2:33,574,623...33,599,485
Ensembl chr 2:33,574,623...33,599,485
|
|
| G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions increases expression
|
EXP
|
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased expression of CDKN1A protein] Carbofuran results in increased expression of CDKN1A mRNA; Carbofuran results in increased expression of CDKN1A protein
|
CTD |
PMID:28982980 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
| G
|
Ch25h
|
cholesterol 25-hydroxylase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CH25H mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:241,428,048...241,429,366
Ensembl chr 1:241,331,619...241,431,190
|
|
| G
|
Cnp
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of CNP mRNA; Carbofuran results in decreased expression of CNP protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr10:86,011,504...86,018,063
Ensembl chr10:86,011,495...86,018,063
|
|
| G
|
Crem
|
cAMP responsive element modulator
|
increases expression
|
EXP
|
Carbofuran results in increased expression of CREM mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160
|
|
| G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
increases hydroxylation
|
ISO
|
CYP1A2 protein results in increased hydroxylation of Carbofuran
|
CTD |
PMID:15560889 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases expression
|
ISO
|
Carbofuran results in increased activity of CYP2B6 protein Carbofuran results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
increases hydroxylation
|
ISO
|
CYP2C19 protein results in increased hydroxylation of Carbofuran
|
CTD |
PMID:15560889 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases hydroxylation multiple interactions increases expression increases chemical synthesis increases activity
|
ISO
|
CYP3A4 protein results in increased hydroxylation of Carbofuran [CYP3A4 protein results in increased metabolism of benfuracarb] which results in increased chemical synthesis of Carbofuran; Carbofuran promotes the reaction [CYP3A4 protein affects the metabolism of Testosterone]; Chlorpyrifos inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Carbofuran]; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Carbofuran] Carbofuran results in increased expression of CYP3A4 mRNA CYP3A4 protein results in increased chemical synthesis of Carbofuran Carbofuran results in increased activity of CYP3A4 protein
|
CTD |
PMID:15560889 PMID:22310298 PMID:24016712 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Dcx
|
doublecortin
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of DCX mRNA; Carbofuran results in decreased expression of DCX protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of DCX protein]
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr X:112,227,455...112,370,291
Ensembl chr X:112,227,455...112,304,161
|
|
| G
|
Fabp3
|
fatty acid binding protein 3
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FABP3 protein
|
CTD |
PMID:19854236 |
|
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881
|
|
| G
|
Fcgr2b
|
Fc gamma receptor 2B
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FCGR2B mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
|
|
| G
|
Fhl1
|
four and a half LIM domains 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FHL1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:139,592,604...139,652,282
|
|
| G
|
Fosl1
|
FOS like 1, AP-1 transcription factor subunit
|
increases expression
|
EXP
|
Carbofuran results in increased expression of FOSL1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391
|
|
| G
|
Gfap
|
glial fibrillary acidic protein
|
decreases expression increases expression
|
EXP
|
Carbofuran results in decreased expression of GFAP protein Carbofuran results in increased expression of GFAP mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:88,352,986...88,361,685
|
|
| G
|
Gpt
|
glutamic--pyruvic transaminase
|
multiple interactions increases activity
|
EXP
|
Plant Extracts inhibits the reaction [Carbofuran results in increased activity of GPT protein]; Silymarin inhibits the reaction [Carbofuran results in increased activity of GPT protein]
|
CTD |
PMID:19778259 PMID:31334637 PMID:31696704 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160
|
|
| G
|
Gria2
|
glutamate ionotropic receptor AMPA type subunit 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of GRIA2 protein
|
CTD |
PMID:28725974 |
|
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616
|
|
| G
|
Hamp
|
hepcidin antimicrobial peptide
|
increases expression
|
EXP
|
Carbofuran results in increased expression of HAMP mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:95,298,307...95,300,297
|
|
| G
|
Hspa2
|
heat shock protein family A (Hsp70) member 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of HSPA2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133
|
|
| G
|
Il2
|
interleukin 2
|
decreases response to substance
|
ISO
|
Carbofuran results in decreased susceptibility to IL2 protein
|
CTD |
PMID:8349949 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
|
|
| G
|
Klhl40
|
kelch-like family member 40
|
increases expression
|
EXP
|
Carbofuran results in increased expression of KLHL40 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 8:130,318,793...130,324,309
Ensembl chr 8:130,318,794...130,326,299
|
|
| G
|
Klhl41
|
kelch-like family member 41
|
increases expression
|
EXP
|
Carbofuran results in increased expression of KLHL41 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 3:74,842,118...74,855,244
|
|
| G
|
Ldlr
|
low density lipoprotein receptor
|
affects response to substance
|
ISO
|
LDLR gene SNP affects the susceptibility to Carbofuran
|
CTD |
PMID:22919386 |
|
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675
|
|
| G
|
Lmcd1
|
LIM and cysteine-rich domains 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of LMCD1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:146,948,993...147,007,878
Ensembl chr 4:146,948,958...147,007,875
|
|
| G
|
Mag
|
myelin-associated glycoprotein
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MAG mRNA; Carbofuran results in decreased expression of MAG protein
|
CTD |
PMID:30471306 |
|
NCBI chr 1:95,275,728...95,291,133
Ensembl chr 1:95,275,635...95,291,060
|
|
| G
|
Mbp
|
myelin basic protein
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MBP mRNA; Carbofuran results in decreased expression of MBP protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174
|
|
| G
|
Mtnr1a
|
melatonin receptor 1A
|
affects binding multiple interactions
|
ISO
|
Carbofuran binds to MTNR1A protein Carbofuran inhibits the reaction [Melatonin binds to MTNR1A protein]
|
CTD |
PMID:28027439 |
|
NCBI chr16:53,876,964...53,896,421
Ensembl chr16:53,876,964...53,896,421
|
|
| G
|
Mtnr1b
|
melatonin receptor 1B
|
affects binding multiple interactions
|
ISO
|
Carbofuran binds to MTNR1B protein Carbofuran inhibits the reaction [Melatonin binds to MTNR1B protein]; Guanosine Triphosphate inhibits the reaction [Carbofuran inhibits the reaction [Melatonin binds to MTNR1B protein]]
|
CTD |
PMID:28027439 |
|
NCBI chr 8:20,919,593...20,934,109
Ensembl chr 8:20,919,593...20,934,109
|
|
| G
|
Myc
|
MYC proto-oncogene, bHLH transcription factor
|
increases expression multiple interactions
|
EXP ISO
|
Carbofuran results in increased expression of MYC mRNA Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of MYC gene
|
CTD |
PMID:20211217 PMID:22445671 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
|
|
| G
|
Myl1
|
myosin, light chain 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of MYL1 protein
|
CTD |
PMID:19854236 |
|
Ensembl chr 9:75,887,227...75,907,971
|
|
| G
|
Myrf
|
myelin regulatory factor
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of MYRF mRNA
|
CTD |
PMID:30471306 |
|
NCBI chr 1:216,279,057...216,311,155
Ensembl chr 1:216,279,057...216,311,178
|
|
| G
|
Nes
|
nestin
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NES mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228
|
|
| G
|
Neurod1
|
neuronal differentiation 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NEUROD1 mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr 3:84,766,483...84,770,454
Ensembl chr 3:84,764,725...84,770,810
|
|
| G
|
Neurog2
|
neurogenin 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NEUROG2 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr 2:218,767,205...218,769,772
Ensembl chr 2:218,765,949...218,769,784
|
|
| G
|
Nrg1
|
neuregulin 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of NRG1 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849
|
|
| G
|
Olig1
|
oligodendrocyte transcription factor 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of OLIG1 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr11:44,000,450...44,002,592
Ensembl chr11:44,000,281...44,002,592
|
|
| G
|
Olig2
|
oligodendrocyte transcription factor 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of OLIG2 mRNA; Carbofuran results in decreased expression of OLIG2 protein
|
CTD |
PMID:30471306 |
|
NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634
|
|
| G
|
Pax6
|
paired box 6
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PAX6 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763
|
|
| G
|
Pdgfra
|
platelet derived growth factor receptor alpha
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PDGFRA mRNA; Carbofuran results in decreased expression of PDGFRA protein
|
CTD |
PMID:30471306 |
|
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
|
|
| G
|
Pla2g4a
|
phospholipase A2 group 4A
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PLA2G4A mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641
|
|
| G
|
Plau
|
plasminogen activator, urokinase
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PLAU mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030
|
|
| G
|
Plp1
|
proteolipid protein 1
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of PLP1 mRNA; Carbofuran results in decreased expression of PLP1 protein
|
CTD |
PMID:30471306 |
|
NCBI chr X:104,933,921...104,993,317
Ensembl chr X:104,975,780...104,993,314
|
|
| G
|
Pvr
|
PVR cell adhesion molecule
|
increases expression
|
EXP
|
Carbofuran results in increased expression of PVR mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 1:88,689,235...88,704,641
Ensembl chr 1:88,688,981...88,704,630
|
|
| G
|
Rbfox3
|
RNA binding fox-1 homolog 3
|
decreases expression multiple interactions
|
EXP
|
Carbofuran results in decreased expression of RBFOX3 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in decreased expression of RBFOX3 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr10:104,218,940...104,655,863
Ensembl chr10:104,218,940...104,551,945
|
|
| G
|
Reg3b
|
regenerating family member 3 beta
|
increases expression
|
EXP
|
Carbofuran results in increased expression of REG3B mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014
|
|
| G
|
Rnd1
|
Rho family GTPase 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of RND1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr 7:131,700,321...131,707,392
Ensembl chr 7:131,700,321...131,707,392
|
|
| G
|
S100b
|
S100 calcium binding protein B
|
increases expression
|
EXP
|
Carbofuran results in increased expression of S100B mRNA; Carbofuran results in increased expression of S100B protein
|
CTD |
PMID:28982980 PMID:30471306 |
|
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,348...12,381,081
|
|
| G
|
Serpine1
|
serpin family E member 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of SERPINE1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
|
|
| G
|
Smad2
|
SMAD family member 2
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Carbofuran results in increased expression of SMAD2 mRNA 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased phosphorylation of SMAD2 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:72,124,863...72,187,388
|
|
| G
|
Smad3
|
SMAD family member 3
|
increases expression multiple interactions increases phosphorylation
|
EXP
|
Carbofuran results in increased expression of SMAD3 mRNA 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Carbofuran results in increased phosphorylation of SMAD3 protein]
|
CTD |
PMID:28982980 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:73,024,760...73,132,324
|
|
| G
|
Smad7
|
SMAD family member 7
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SMAD7 mRNA; Carbofuran results in decreased expression of SMAD7 protein
|
CTD |
PMID:28982980 |
|
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:71,263,508...71,291,849
|
|
| G
|
Smurf2
|
SMAD specific E3 ubiquitin protein ligase 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SMURF2 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr10:92,261,516...92,362,185
Ensembl chr10:92,261,525...92,362,552
|
|
| G
|
Sox2
|
SRY-box transcription factor 2
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of SOX2 protein
|
CTD |
PMID:22240977 |
|
NCBI chr 2:119,465,131...119,467,542
Ensembl chr 2:119,454,541...119,496,350
|
|
| G
|
Spp1
|
secreted phosphoprotein 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of SPP1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
| G
|
Stat3
|
signal transducer and activator of transcription 3
|
increases expression
|
EXP
|
Carbofuran results in increased expression of STAT3 mRNA
|
CTD |
PMID:22240977 PMID:28982980 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
| G
|
Tgfb1
|
transforming growth factor, beta 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TGFB1 mRNA; Carbofuran results in increased expression of TGFB1 protein
|
CTD |
PMID:28982980 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
| G
|
Tgfb2
|
transforming growth factor, beta 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TGFB2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:100,691,540...100,793,227
Ensembl chr13:100,692,953...100,792,856
|
|
| G
|
Tiam1
|
TIAM Rac1 associated GEF 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TIAM1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr11:42,517,527...42,866,280
Ensembl chr11:42,517,528...42,646,075
|
|
| G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TIMP1 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
| G
|
Tnni3
|
troponin I3, cardiac type
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TNNI3 protein
|
CTD |
PMID:19854236 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:78,342,592...78,346,253
|
|
| G
|
Tnnt2
|
troponin T2, cardiac type
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TNNT2 protein
|
CTD |
PMID:19854236 |
|
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:49,822,304...49,837,125
|
|
| G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO
|
Carbofuran results in decreased stability of and results in increased degradation of and results in increased mutagenesis of TP53 gene
|
CTD |
PMID:22445671 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
| G
|
Tubb3
|
tubulin, beta 3 class III
|
decreases expression
|
EXP
|
Carbofuran results in decreased expression of TUBB3 mRNA
|
CTD |
PMID:28982980 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:68,365,587...68,374,740
|
|
| G
|
Tubb6
|
tubulin, beta 6 class V
|
increases expression
|
EXP
|
Carbofuran results in increased expression of TUBB6 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr18:63,213,287...63,222,926
Ensembl chr18:63,213,279...63,224,303
|
|
| G
|
Uck2
|
uridine-cytidine kinase 2
|
increases expression
|
EXP
|
Carbofuran results in increased expression of UCK2 mRNA
|
CTD |
PMID:20211217 |
|
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:81,916,818...81,971,091
|
|
| G
|
Vcan
|
versican
|
increases expression decreases expression
|
EXP
|
Carbofuran results in increased expression of VCAN mRNA Carbofuran results in decreased expression of VCAN mRNA
|
CTD |
PMID:20211217 PMID:30471306 |
|
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:22,497,035...22,595,955
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP ISO
|
carbosulfan results in decreased activity of ACHE protein carbosulfan metabolite results in decreased activity of ACHE protein; carbosulfan results in decreased activity of ACHE protein
|
CTD |
PMID:3710030 PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases activity increases metabolic processing increases expression
|
ISO
|
carbosulfan results in increased activity of CYP2B6 protein CYP2B6 protein results in increased metabolism of carbosulfan carbosulfan results in increased expression of CYP2B6 mRNA
|
CTD |
PMID:20307514 PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
multiple interactions decreases activity increases activity increases expression
|
ISO
|
CYP3A4 protein results in increased metabolism of and results in increased activity of carbosulfan; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of carbosulfan] carbosulfan results in decreased activity of CYP3A4 protein carbosulfan results in increased activity of CYP3A4 protein carbosulfan results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:20307514 PMID:22310298 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
increases metabolic processing
|
ISO
|
CYP3A5 protein results in increased metabolism of carbosulfan
|
CTD |
PMID:20307514 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases expression
|
ISO
|
carbosulfan results in increased expression of NR1I3 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
|
|
| G
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1
|
multiple interactions
|
ISO
|
croneton inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]
|
CTD |
PMID:26647222 |
|
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP
|
formetanate results in decreased activity of ACHE protein
|
CTD |
PMID:19934164 PMID:21251949 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
EXP
|
[Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
decreases expression
|
ISO
|
formetanate results in decreased expression of HSPA1A protein
|
CTD |
PMID:16271832 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
formetanate results in increased expression of HSPA5 protein
|
CTD |
PMID:16271832 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
decreases expression
|
ISO
|
formetanate results in decreased expression of HSPA8 protein
|
CTD |
PMID:16271832 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
increases activity
|
ISO
|
formetanate results in increased activity of NFE2L2 protein
|
CTD |
PMID:20143881 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
decreases activity
|
ISO
|
formetanate results in decreased activity of PARK7 protein
|
CTD |
PMID:36842454 |
|
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
|
|
| G
|
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3
|
increases expression increases activity
|
ISO
|
deltanit results in increased expression of CYP2B6 mRNA deltanit results in increased activity of CYP2B6 protein
|
CTD |
PMID:22310298 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
| G
|
Cyp3a2
|
cytochrome P450, family 3, subfamily a, polypeptide 2
|
increases activity increases expression
|
ISO
|
deltanit results in increased activity of CYP3A4 protein deltanit results in increased expression of CYP3A4 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
|
|
| G
|
Nr1i3
|
nuclear receptor subfamily 1, group I, member 3
|
increases expression
|
ISO
|
deltanit results in increased expression of NR1I3 mRNA
|
CTD |
PMID:22310298 |
|
NCBI chr13:86,165,327...86,170,362
Ensembl chr13:86,165,349...86,170,370
|
|
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
isoprocarb metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Thrb
|
thyroid hormone receptor beta
|
affects binding
|
ISO
|
metolcarb binds to THRB protein
|
CTD |
PMID:28973306 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
EXP ISO
|
oxamyl results in decreased activity of ACHE protein
|
CTD |
PMID:19934164 PMID:21251949 PMID:27132127 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
EXP
|
[Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
oxamyl inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Park7
|
Parkinsonism associated deglycase
|
decreases activity
|
ISO
|
oxamyl results in decreased activity of PARK7 protein
|
CTD |
PMID:36842454 |
|
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:166,636,552...166,659,825
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
oxamyl inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
| G
|
Pon1
|
paraoxonase 1
|
multiple interactions
|
ISO EXP
|
[Calcium results in increased activity of PON1 protein] which results in decreased susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which results in increased susceptibility to oxamyl [Calcium results in increased activity of PON1 protein] which affects the susceptibility to oxamyl; [Egtazic Acid results in decreased activity of PON1 protein] which affects the susceptibility to oxamyl
|
CTD |
PMID:27132127 |
|
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
oxamyl metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO
|
pirimicarb results in decreased activity of ACHE protein
|
CTD |
PMID:33037899 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Cyp19a1
|
cytochrome P450, family 19, subfamily a, polypeptide 1
|
increases activity
|
ISO
|
pirimicarb results in increased activity of CYP19A1 protein
|
CTD |
PMID:11884232 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
|
|
| G
|
Esr1
|
estrogen receptor 1
|
decreases expression
|
ISO
|
pirimicarb results in decreased expression of ESR1 mRNA
|
CTD |
PMID:15261991 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Hspa1a
|
heat shock protein family A (Hsp70) member 1A
|
decreases expression
|
ISO
|
pirimicarb results in decreased expression of HSPA1A protein
|
CTD |
PMID:16271832 |
|
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979
|
|
| G
|
Hspa5
|
heat shock protein family A (Hsp70) member 5
|
increases expression
|
ISO
|
pirimicarb results in increased expression of HSPA5 protein
|
CTD |
PMID:16271832 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
|
|
| G
|
Hspa8
|
heat shock protein family A (Hsp70) member 8
|
decreases expression
|
ISO
|
pirimicarb results in decreased expression of HSPA8 protein
|
CTD |
PMID:16271832 |
|
NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
|
|
| G
|
Hspb2
|
heat shock protein family B (small) member 2
|
decreases expression
|
ISO
|
pirimicarb results in decreased expression of HSPB2 protein
|
CTD |
PMID:16271832 |
|
NCBI chr 8:59,989,640...59,991,215
Ensembl chr 8:59,976,623...59,990,901
|
|
| G
|
Lep
|
leptin
|
multiple interactions
|
EXP
|
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of LEP protein
|
CTD |
PMID:29321614 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661
|
|
| G
|
Lepr
|
leptin receptor
|
multiple interactions
|
EXP
|
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of LEPR mRNA
|
CTD |
PMID:29321614 |
|
NCBI chr 5:121,409,735...121,593,201
Ensembl chr 5:121,474,099...121,591,215
|
|
| G
|
Nmb
|
neuromedin B
|
multiple interactions
|
EXP
|
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA
|
CTD |
PMID:29321614 |
|
NCBI chr 1:144,278,678...144,290,523
Ensembl chr 1:144,278,453...144,281,422
|
|
| G
|
Nmbr
|
neuromedin B receptor
|
multiple interactions
|
EXP
|
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NMBR mRNA
|
CTD |
PMID:29321614 |
|
NCBI chr 1:10,942,476...10,966,174
Ensembl chr 1:10,954,916...10,965,555
|
|
| G
|
Npy1r
|
neuropeptide Y receptor Y1
|
multiple interactions
|
EXP
|
[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in increased expression of NPY1R mRNA
|
CTD |
PMID:29321614 |
|
NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387
|
|
| G
|
Tp53
|
tumor protein p53
|
affects activity
|
ISO
|
pirimicarb metabolite affects the activity of TP53 protein
|
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
multiple interactions decreases activity
|
ISO EXP
|
Obidoxime Chloride promotes the reaction [Propoxur results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [Propoxur results in decreased activity of ACHE protein]
|
CTD |
PMID:14644616 PMID:19934164 PMID:21251949 PMID:23962483 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Bche
|
butyrylcholinesterase
|
multiple interactions
|
EXP
|
[Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein
|
CTD |
PMID:22649187 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760
|
|
| G
|
Cat
|
catalase
|
multiple interactions decreases activity
|
EXP
|
[Propoxur co-treated with Permethrin] results in increased activity of CAT protein; Melatonin inhibits the reaction [Propoxur results in decreased activity of CAT protein]
|
CTD |
PMID:24733834 PMID:28456543 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Chrna4
|
cholinergic receptor nicotinic alpha 4 subunit
|
multiple interactions
|
EXP
|
Propoxur results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
|
|
| G
|
Chrnb4
|
cholinergic receptor nicotinic beta 4 subunit
|
multiple interactions
|
EXP
|
Propoxur results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]
|
CTD |
PMID:14644616 |
|
NCBI chr 8:64,312,644...64,333,319
Ensembl chr 8:64,313,669...64,333,248
|
|
| G
|
Esr1
|
estrogen receptor 1
|
multiple interactions
|
ISO
|
Propoxur inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
| G
|
Pgr
|
progesterone receptor
|
multiple interactions
|
ISO
|
Propoxur inhibits the reaction [Progesterone results in increased activity of PGR protein]
|
CTD |
PMID:9126867 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
|
|
| G
|
Ache
|
acetylcholinesterase
|
decreases activity
|
ISO EXP
|
thiodicarb results in decreased activity of ACHE protein
|
CTD |
PMID:21251949 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|